FARIBORZ NAZARI-ADLI: Open Payments
NPI 1760577019 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,413 in 185 payments from 30 companies in 2025. Trend: 2023 $3,850 · 2024 $3,702 · 2025 $3,413
Food & beverage: $3,334Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $511 |
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $508 |
| Lilly USA, LLC | 26 | $367 |
| Dexcom, Inc. | 22 | $271 |
| ABBVIE INC. | 17 | $189 |
| Merck Sharp & Dohme LLC | 9 | $171 |
| Amgen Inc. | 20 | $162 |
| Astellas Pharma US Inc | 5 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| Tandem Diabetes Care, Inc. | 3 | $91 |
Products named: Kerendia, FARXIGA, JARDIANCE, Dexcom G6 Transmitter, MOUNJARO, OTEZLA, VERQUVO, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
